Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/30/2008
 
First Published:
10/31/2007
1.
Phase I/II Study of 3-Dimensional Conformal Radiotherapy, Intra- or Peri-Tumoral Injection of Poly ICLC With Trans-Hepatic Arterial Embolization Followed by Autologous Tumor Cell Vaccine Poly ICLC in Patients With Unresectable, Recurrent, or Metastatic Primary Hepatocellular or Pancreatic Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 and over
Other
UMDNJ-0120070076
0120070076, NCT00553683
2.
Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
Over 18
Other
05-115
RO1 NS055140, NCT00766753
3.
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Active
18 and over
NCI, Other
MCC-15262
USFIRB #106346, NCT00694551
4.
Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Active
18 and over
Other
07-057
R21CA133859-01A1, NCT00795457
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute